-
Mashup Score: 135Help us ensure access to fair and competitive healthcare markets for you and your family. - 2 day(s) ago
Everyone deserves access to a competitive healthcare marketplace. If you need medical care, fair competition helps lower the price you pay and improve the quality of your care. If your job is in healthcare, competition helps you get a fair wage and opportunities to grow. The Department of Justice’s Antitrust Division, the Federal Trade Commission, and the Department of Health and Human Services work to promote competitive and fair healthcare markets. Information from the public is vital to our work. If
Source: www.justice.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 57Gukesh wins Candidates tournament, becomes youngest challenger in history of World Chess Championship - 6 day(s) ago
D. Gukesh qualifies for World chess championship as youngest challenger, while Tan Zhongyi wins women’s tournament.
Source: www.thehindu.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 104Help us ensure access to fair and competitive healthcare markets for you and your family. - 9 day(s) ago
Everyone deserves access to a competitive healthcare marketplace. If you need medical care, fair competition helps lower the price you pay and improve the quality of your care. If your job is in healthcare, competition helps you get a fair wage and opportunities to grow. The Department of Justice’s Antitrust Division, the Federal Trade Commission, and the Department of Health and Human Services work to promote competitive and fair healthcare markets. Information from the public is vital to our work. If
Source: www.justice.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 138
ODAC voted on the risk/benefit ratio of cilta-cel vs standard of care for patients with lenalidomide-refractory multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 129
ODAC voted on the risk/benefit ratio of cilta-cel vs standard of care for patients with lenalidomide-refractory multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 129
ODAC voted on the risk/benefit ratio of cilta-cel vs standard of care for patients with lenalidomide-refractory multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 123
ODAC voted on the risk/benefit ratio of cilta-cel vs standard of care for patients with lenalidomide-refractory multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 122
ODAC voted on the risk/benefit ratio of cilta-cel vs standard of care for patients with lenalidomide-refractory multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 122
ODAC voted on the risk/benefit ratio of cilta-cel vs standard of care for patients with lenalidomide-refractory multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
The US Department of Justice has sought comments on burdens imposed on physicians by certifying bodies. I’m posting a detailed comment on the burdens of ABIM MOC and a request for the government end MOC. https://t.co/79VC0uhv6J https://t.co/5ZEwxri4JG